What is the current valuation of the US skin graft market as of 2024?

The overall market valuation was $500.0 Million in 2024. Read More

What is the projected market valuation for the US skin graft market in 2035?

The projected valuation for 2035 is $1100.0 Million. Read More

What is the expected CAGR for the US skin graft market during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 7.43%. Read More

Which companies are considered key players in the US skin graft market?

Key players include Integra LifeSciences, MediWound Ltd., Smith & Nephew, Organogenesis Holdings Inc., Acelity L.P. Inc., Sientra Inc., Medi-Globe Technologies, and KCI Medical. Read More

What are the main types of grafts in the US skin graft market and their valuations?

The main graft types include Autograft valued at $200.0 - $440.0 Million, Allograft at $150.0 - $330.0 Million, and Xenograft at $150.0 - $330.0 Million. Read More

What product types are included in the US skin graft market and their respective valuations?

Product types include Dermatome at $150.0 - $330.0 Million, Powered Dermatome at $120.0 - $270.0 Million, and Wound Debridement Devices at $100.0 - $220.0 Million. Read More

What applications are driving the US skin graft market and their valuations?

Applications include Surgical Wounds valued at $150.0 - $350.0 Million, Burns at $120.0 - $250.0 Million, and Diabetic Foot Ulcers at $80.0 - $180.0 Million. Read More

Who are the primary end users of skin grafts in the US market?

Primary end users include Hospitals valued at $200.0 - $440.0 Million, Ambulatory Surgery Centers at $150.0 - $330.0 Million, and Specialty Centers at $150.0 - $330.0 Million. Read More

How does the US skin graft market compare to its projected growth by 2035?

The market is expected to grow from $500.0 Million in 2024 to $1100.0 Million by 2035, indicating robust growth. Read More

What trends are influencing the US skin graft market in 2025?

Trends include advancements in graft technology and increasing demand for effective wound care solutions. Read More

US Skin Graft Market

ID: MRFR/MED/17978-HCR

100 Pages

Nidhi Mandole

Last Updated: May 05, 2026

US Skin Graft Market Research Report By Type (Isogeneic, Autologous, Allogeneic, Xenogeneic, Prosthetic), By Thickness (Split-Thickness, Full-Thickness, Composite Graft), By Application (Extensive Wound, Burns, Extensive Skin Loss Due To Infection, Skin Cancers, Others), By Equipment (Dermatome, Knives Dermatomes, Drum Dermatomes, Electric Dermatomes, Air Dermatomes, General Surgical Instruments, Consumables, Others) and By End User (Hospitals And Clinics, Academic And Research, Others) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Medical Device, BY Graft Type (USD Million) | |
  1. 4.1.1 Autograft | |
  2. 4.1.2 Allograft | |
  3. 4.1.3 Xenograft |
2. 4.2 Medical Device, BY Product Type (USD Million) | |
  1. 4.2.1 Dermatome | |
  2. 4.2.2 Powered Dermatome | |
  3. 4.2.3 Drum and Knife Dermatome | |
  4. 4.2.4 Wound Debridement Devices | |
  5. 4.2.5 Others |
3. 4.3 Medical Device, BY Application (USD Million) | |
  1. 4.3.1 Pressure & Venous Ulcers | |
  2. 4.3.2 Diabetic Foot Ulcers | |
  3. 4.3.3 Burns | |
  4. 4.3.4 Surgical Wounds | |
  5. 4.3.5 Others |
4. 4.4 Medical Device, BY End User (USD Million) | |
  1. 4.4.1 Hospitals | |
  2. 4.4.2 Ambulatory Surgery Centers | |
  3. 4.4.3 Specialty Centers 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Medical Device | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Integra LifeSciences (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 MediWound Ltd. (IL) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Smith & Nephew (GB) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Organogenesis Holdings Inc. (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Acelity L.P. Inc. (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Sientra Inc. (US) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Medi-Globe Technologies (DE) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 KCI Medical (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 US MARKET ANALYSIS BY GRAFT TYPE |
6. 6.3 US MARKET ANALYSIS BY PRODUCT TYPE |
7. 6.4 US MARKET ANALYSIS BY APPLICATION |
8. 6.5 US MARKET ANALYSIS BY END USER |
9. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF MEDICAL DEVICE |
12. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE |
14. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE |
15. 6.12 MEDICAL DEVICE, BY GRAFT TYPE, 2024 (% SHARE) |
16. 6.13 MEDICAL DEVICE, BY GRAFT TYPE, 2024 TO 2035 (USD Million) |
17. 6.14 MEDICAL DEVICE, BY PRODUCT TYPE, 2024 (% SHARE) |
18. 6.15 MEDICAL DEVICE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million) |
19. 6.16 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE) |
20. 6.17 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million) |
21. 6.18 MEDICAL DEVICE, BY END USER, 2024 (% SHARE) |
22. 6.19 MEDICAL DEVICE, BY END USER, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY GRAFT TYPE, 2025-2035 (USD Million) | |
  2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Million) | |
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million) | |
  4. 7.2.4 BY END USER, 2025-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

US Medical Device Market Segmentation

Medical Device By Graft Type (USD Million, 2025-2035)

Autograft
Allograft
Xenograft

Medical Device By Product Type (USD Million, 2025-2035)

Dermatome
Powered Dermatome
Drum and Knife Dermatome
Wound Debridement Devices
Others

Medical Device By Application (USD Million, 2025-2035)

Pressure & Venous Ulcers
Diabetic Foot Ulcers
Burns
Surgical Wounds
Others

Medical Device By End User (USD Million, 2025-2035)

Hospitals
Ambulatory Surgery Centers
Specialty Centers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”